Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
Clinical trial NCT01788020 · COMPLETED
Trial details
- NCT number
- NCT01788020
- Sponsor
- University of Ulm
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2018-11-01
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.